Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized StudyLeyi Lin, Alexander C. Schmidt, Jeffrey R. Currier et al.|American Journal of Tropical Medicine and Hygiene|2020Cited by 17
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I StudyClemente Díaz, Stephen J. Thomas, Luis Javier Martínez-González et al.|American Journal of Tropical Medicine and Hygiene|2020Cited by 15